A Virginia federal judge ruled that the FDA's special certification requirement for prescribing mifepristone is illegal, citing lack of justification given the drug's proven safety and effectiveness.
A Planned Parenthood affiliate has launched "Just In Case Abortion Pills," allowing people to stock up on abortion medication for future use. This initiative aims to provide access amid growing abortion restrictions and legal challenges, offering a proactive approach to reproductive healthcare.
The Supreme Court upheld access to the abortion pill mifepristone, Trump returned from a state visit to China with announced but unconfirmed purchases, and the UK faces political turmoil with challenges to Prime Minister Keir Starmer's leadership.
The Supreme Court stayed a 5th Circuit ruling, allowing mifepristone abortion pills to remain available via telehealth nationwide while a Louisiana case proceeds.
The Supreme Court stayed a ruling that would have banned mifepristone from being mailed, keeping telehealth abortion access intact as a case proceeds through lower courts.
The Supreme Court has temporarily allowed mail orders of the abortion drug mifepristone while an appeal by Louisiana against the FDA's distribution rules is pending, with Justices Thomas and Alito dissenting.
US military shot down drones and missiles, sank Iranian boats in Strait of Hormuz operation. Trump targets incumbents in Indiana primaries. Supreme Court pauses mifepristone prescription changes.
The Supreme Court on Monday restored broad access to the abortion pill mifepristone, blocking a ruling that had threatened to upend one of the main ways abortion is provided across the nation. The order signed by Justice Samuel Alito temporarily allows women seeking abortions to obtain the pill at pharmacies or through the mail, without an in-person visit to a doctor. Those rules had been in effect for several years until a federal appeal court imposed new restrictions last week. Most abortions...
Danco Laboratories, maker of the abortion pill mifepristone, asked the Supreme Court to intervene after the Fifth Circuit Court of Appeals temporarily reinstated a requirement that the pill be obtained in person. The ruling overrides a 2023 FDA decision allowing telemedicine prescriptions and mail-order delivery, effectively curbing access in states where abortion is banned. The case stems from a lawsuit by Louisiana, and the decision will remain in effect as the litigation continues.
Danco Laboratories filed an emergency appeal to the US Supreme Court on May 2 asking it to halt a lower court ruling requiring in-person exams before mifepristone can be prescribed. The appeal came hours after the 5th Circuit Court of Appeals temporarily reinstated the in-person dispensing requirement, blocking telemedicine providers from prescribing the abortion pill by mail in response to Louisiana's challenge. Danco warned the ruling would cause chaos and force providers and patients to guess at what is allowed. Louisiana argues mail delivery allows women to bypass abortion bans. The FDA is currently reviewing the drug's safety.
The Fifth Circuit Court of Appeals issued an order temporarily reinstating the in-person requirement for obtaining the abortion pill mifepristone, reversing a 2023 FDA regulation that allowed telemedicine prescriptions and mail delivery. The decision, stemming from a Louisiana lawsuit, specifically impacts states where abortion is banned, restricting the most common method of pregnancy termination in the US. The ruling overrides a lower court pause from earlier this month and has drawn criticism from abortion rights advocates while being celebrated by anti-abortion officials.
A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone.
